Ekso Bionics (EKSO) - Rasio tanggungan utang jangka dawa marang modal

Ekso Bionics Holdings (EKSO) generates revenue through the implementation of robotics in medicine and industry, which, when compared with the long-term debt load chart on GURU.Markets, confirms that 1.94 is becoming the new value for this metric. Stable demand from clinics ensures cash flow, although production costs are weighing on margins. The company's leadership is bolstered by massive R&D investments in AI algorithms for movement synchronization.

Investors must balance the growth potential of the shares against the business's debt load. This ratio measures the proportion of liabilities with a maturity of more than one year relative to shareholders' equity. By analyzing the long-term debt-to-equity ratio, one can assess financial stability and default risk. An optimal level of borrowing allows Ekso Bionics Holdings (EKSO) to scale the expansion of exoskeletons in medicine. Experienced management utilizes this leverage to expand insurance coverage for clients.